Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $45.90 | Total: $229.50 |
| 1 | 10 | $38.88 | Total: $388.80 |
| 1 | 25 | $32.94 | Total: $823.50 |
| 1 | 50 | $28.08 | Total: $1,404.00 |
| 1 | 100 | $24.30 | Total: $2,430.00 |
Overview
CMPF is a microtubule protein inhibitor that can be used to study tumors.
Chemical Properties
| Molecular Formula | C12H16O5 |
| Molecular Weight | 240.25 |
| CAS Numbers | 86879-39-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CC(O)=O)C1=C(C(O)=O)C(C)=C(CCC)O1 |
Storage and Handling
0C Short Term, -20C Long Term
References
Dai L, et al. The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease results from the European QUALity [EQUAL] Study. Am J Clin Nutr. 2022;116[6] 1842-1851.